I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 18 studies | 54% ± 14% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 18 studies | 54% ± 14% |
Insufficient scRNA-seq data for expression of CFAP52 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 81% | 204.80 | 2140 / 2642 | 79% | 4.69 | 559 / 705 |
| lung | 81% | 394.44 | 470 / 578 | 32% | 1.75 | 375 / 1155 |
| prostate | 79% | 31.39 | 194 / 245 | 24% | 0.54 | 119 / 502 |
| kidney | 66% | 20.98 | 59 / 89 | 23% | 0.49 | 206 / 901 |
| ovary | 47% | 16.26 | 84 / 180 | 37% | 1.27 | 157 / 430 |
| thymus | 80% | 27.27 | 523 / 653 | 3% | 0.05 | 17 / 605 |
| adrenal gland | 41% | 10.81 | 105 / 258 | 17% | 0.35 | 39 / 230 |
| uterus | 42% | 103.61 | 72 / 170 | 13% | 0.69 | 59 / 459 |
| breast | 31% | 8.19 | 142 / 459 | 11% | 0.30 | 118 / 1118 |
| bladder | 33% | 6.00 | 7 / 21 | 8% | 0.19 | 41 / 504 |
| esophagus | 17% | 3.80 | 247 / 1445 | 16% | 0.22 | 30 / 183 |
| intestine | 21% | 4.81 | 204 / 966 | 4% | 0.11 | 22 / 527 |
| pancreas | 14% | 3.05 | 47 / 328 | 6% | 0.34 | 11 / 178 |
| liver | 17% | 3.92 | 39 / 226 | 1% | 0.01 | 4 / 406 |
| stomach | 8% | 1.79 | 29 / 359 | 4% | 0.06 | 11 / 286 |
| blood vessel | 12% | 2.50 | 158 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 10% | 2.00 | 115 / 1204 | 0% | 0 | 0 / 0 |
| skin | 7% | 1.80 | 134 / 1809 | 1% | 0.05 | 4 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 4% | 0.07 | 2 / 45 |
| heart | 2% | 0.33 | 15 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
| muscle | 1% | 0.30 | 8 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 1.25 | 4 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030317 | Biological process | flagellated sperm motility |
| GO_0061966 | Biological process | establishment of left/right asymmetry |
| GO_0005930 | Cellular component | axoneme |
| GO_0005879 | Cellular component | axonemal microtubule |
| GO_0097729 | Cellular component | 9+2 motile cilium |
| GO_0160112 | Cellular component | axonemal B tubule inner sheath |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CFAP52 |
| Protein name | Cilia and flagella associated protein 52 Cilia- and flagella-associated protein 52 (WD repeat-containing protein 16) (WD40-repeat protein up-regulated in HCC) |
| Synonyms | WDR16 WDRPUH |
| Description | FUNCTION: Microtubule inner protein (MIP) part of the dynein-decorated doublet microtubules (DMTs) in cilia axoneme . Important for proper ciliary and flagellar beating. May act in cooperation with CFAP45 and axonemal dynein subunit DNAH11 . May play a role in cell growth and/or survival . . |
| Accessions | ENST00000574937.5 ENST00000576630.5 ENST00000575247.5 ENST00000574097.1 ENST00000396219.7 [Q8N1V2-3] ENST00000352665.10 [Q8N1V2-1] A0A096LNH3 I3L2G9 I3L237 K7ERC0 ENST00000576499.1 V9GY13 ENST00000572333.5 Q8N1V2 |
